Study finds new link between HRT and breast cancer risk in young women
Using certain type of HRT before menopause could raise cancer risk - study
- An international study examined the link between hormone replacement therapy (HRT) and young-onset breast cancer in women aged 16 to 54.
- The research found that overall HRT use was not broadly connected to an increased risk of young-onset breast cancer.
- However, oestrogen-only hormone therapy appeared to decrease breast cancer risk by 14 per cent in younger women.
- Conversely, oestrogen plus progestin therapy was associated with a 10 per cent increased risk of young-onset breast cancer.
- These findings offer new guidance for clinical recommendations on HRT use in younger women, where previous information was limited.